Ultime notizie per Remitly Global (NASDAQ:RELY) Azioni

Remitly Global

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Remitly Global Inc

Piper Sandler analyst Arvind Ramnani maintains Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) with a Overweight and raises the price target from $172 to $212.

News

Price Target

Analyst Ratings

PCTY

Piper Sandler Maintains Overweight on Paylocity Holding, Raises Price Target to $212

Piper Sandler analyst Arvind Ramnani maintains Dayforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>) with a Overweight and raises the price target from $71 to $82.

Piper Sandler Maintains Overweight on Dayforce, Raises Price Target to $82

New battery electric vehicle (BEV) registrations in California rose 1% year-on-year to 293,109 units this year as of the end of September, according to data from the California New Car Dealers Association (CNCDA).
What Happened: As per the data, BEVs accounted for 22.2% of new vehicle registrations in California in the nine months, higher than the national BEV market share of 7.9%. 
In fact, California accounted for 32.1% of U.S. BEV registrations as of the end of September this year. 
Tesla Tops The Chart: Tesla Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) new vehicle registrations in the nine months, however, <a href="https://www.benzinga.com/news/24/04/38516918/california-love-fadin-for-tesla-ev-giants-registrations-plummet-as-rivian-mercedes-and-bmw-gain-grou">fell 12.6% </a>as compared to the corresponding period last year to 159,619 units. 
Tesla, however, continues to be the best-selling EV brand in the state, seconded by Hyundai which had 16,433 registrations in the period. 
Rival Player Performance: While General Motors&#8216; brand Chevrolet witnessed BEV registrations fall nearly 42% in the nine months through the end of September, its sister brand Cadillac saw registrations go up by a whopping 315%. 
Michigan-based Ford witnessed a 17% rise in EV registrations and <a href="https://www.benzinga.com/news/24/08/40219148/california-governor-gavin-newsom-slams-elon-musks-tesla-applauds-rivian-after-in-state-zero-emission">Califonia-based Rivian </a>a modest 35% rise to 9,049 units.
Best-Selling EVs: The Model Y was the best-selling EV in the state in the time frame, followed by the Model 3. Tesla&#8217;s Model X SUV and the Cybertruck also feature in the list of top ten best-selling EVs in the state, together with rival models such as the Ford Mustang Mach-E, Hyundai Ioniq 5, and BMW i4.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41645383/elon-musk-slams-zoox-co-founder-over-fsd-criticism-your-company-would-be-dead-already-if-not-for-ama">Elon Musk Slams Zoox Co-Founder Over FSD Criticism: Your Company &#8216;Would Be Dead Already&#8217; If Not For Amazon</a></li>
</ul>
Image via Tesla

Markets

Tech

General

RIVN

TSLA

Tesla Remains California's Top EV Choice Even As Registrations Drop: Cybertruck Among 10 Best-Selling EVs In Golden State

Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.89 by 8.99 percent.

Earnings

Earnings Beats

Canadian Natural Res Q3 2024 Adj. EPS $0.97 Beats $0.89 Estimate

In a bold but unsurprising move, MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) CEO Michael Saylor said the company would advocate for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a treasury reserve asset across global finance.
What Happened: During the company&#8217;s third-quarter earnings call Tuesday, Saylor voiced his conviction in Bitcoin&#8217;s potential to rectify the unhealthy balance sheets of both public and private enterprises.
&#8220;Bitcoin fixes the balance sheet. It&#8217;ll bring your stock back to life. It&#8217;ll bring your options back to life. It&#8217;ll bring volatility,&#8221; Saylor stated.
Saylor said he regularly speaks with executives of public and private companies and highlighted initiatives like &#8220;Bitcoin For Corporations,&#8221; which provide expert advice on the benefits of Bitcoin adoption.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41645548/coinbase-on-following-microstrategys-bitcoin-playbook-looking-for-opportunities-says-cfo-b">Coinbase On Following MicroStrategy&#8217;s Bitcoin Playbook: Looking For &#8216;Opportunities,&#8217; Says CFO, But Highlights Key Difference Between The Two Companies</a>
&#8220;So unlike a lot of industries where you don&#8217;t want competitors in our business, we&#8217;re happy to share the playbook. We&#8217;re happy to advocate. We&#8217;ll show you how to do it,&#8221; MicroStrategy&#8217;s top executive remarked.
Why It Matters: MicroStrategy released its third-quarter financials on Tuesday, revealing a robust Bitcoin investment strategy.
The company said it purchased 25,889 BTCs in the quarter for approximately $1.6 billion at an average price of $60,839, taking its overall stash to 252,220, worth $18.23 billion. 
At an average acquisition price of $9.904 billion, MicroStrategy was up nearly $8.3 billion in profit on its Bitcoin investments.
MicroStrategy also announced that it would raise $42 billion over the next three years through equity and debt financing to buy more Bitcoin. 
In August 2020, MicroStrategy became<a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41645548/coinbase-on-following-microstrategys-bitcoin-playbook-looking-for-opportunities-says-cfo-b"> the first publicly traded company to acquire and hold Bitcoin</a> on its balance sheet as a primary treasury reserve asset.
Since then, it has gained 1989% in value, surpassing some of the biggest names on Wall Street, including artificial intelligence darling Nvidia. 
Interestingly, the company&#8217;s stock has also outperformed Bitcoin, with the leading cryptocurrency gaining just 508% in the said period.
That said, the company&#8217;s net loss widened to $340 million, compared with a loss of $143.4 million in the same quarter last year.
Price Action: At the time of writing, Bitcoin was exchanging hands at $72,173.91, down 0.40% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;Shares of MicroStrategy closed 4.23% lower at $247.31 during Tuesday&#8217;s regular session. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41629253/satoshi-nakamoto-could-soon-be-surpassed-by-blackrock-grayscale-as-top-bitcoin-holder">Satoshi Nakamoto Could Soon Be Surpassed By BlackRock, Grayscale As Top Bitcoin Holder</a></li>
</ul>
Image: Master Tux from Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSFT

MSTR

Michael Saylor Says Bitcoin Remedy To Fix Unhealthy Balance Sheets As MicroStrategy Unveils Massive $42B BTC Purchase Plan

Shares of Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) took a hit, dropping 4.38%, following the resignation of its independent auditor, Ernst &amp; Young. 
What Happened: SMCI closed 32.68% lower at $33.07 on Wednesday and at the time of writing, SMCI was trading at $31.56 during pre-market hours on Thursday, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
The company announced in a regulatory filing that EY had stepped down as its <a href="https://www.benzinga.com/trading-ideas/movers/24/10/41625460/super-micro-computer-stock-dives-as-auditor-resigns-whats-going-on">registered public accounting firm</a>. The auditing firm, which had been engaged since March 2023 to review Super Micro&#8217;s financials for the fiscal year ending June, resigned before completing any reports on the company&#8217;s financials or internal controls.
Back in July, EY raised concerns about governance, transparency, and the completeness of communications, warning that the timely filing of Super Micro&#8217;s annual report was at risk. In response, Super Micro&#8217;s board established a special committee to investigate these issues, which submitted preliminary information to both the company and its auditor.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41590974/dogecoin-lifts-15-amid-rising-odds-of-trump-victory-in-betting-markets-and-expectations-of?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin Lifts 15% Amid Rising Odds Of Trump Victory In Betting Markets And Expectations Of Elon Musk Heading &#8216;DOGE&#8217; Department</a>
The resignation letter from Ernst &amp; Young highlighted a<a href="https://www.benzinga.com/trading-ideas/movers/24/10/41625460/super-micro-computer-stock-dives-as-auditor-resigns-whats-going-on"> lack of confidence</a> in the integrity and ethical values of the company, questioning the board&#8217;s independence and the reliability of information from certain management members. Although Super Micro disagrees with the resignation, it plans to address the concerns raised and continue the investigation.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41616239/shytoshi-kusama-touts-shiba-inu-lifetime-gains-of-33774726-we-still-have-far-to-go-and-muc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Shytoshi Kusama Touts Shiba Inu Lifetime Gains Of 33774726%: &#8216;We Still Have Far To Go And Much Work To Be Done&#8217;</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Pre-Market Outlook

SMCI

Super Micro Computer Stock Plummets Over 4% In Thursday Pre-Market: What's Going On?

Li Auto Q3 Adj. EPADS CNY3.63 Beats CNY2.31 Estimate, Sales CNY42.87B Beats CNY41.665B Estimate

Jack Dorsey, the CEO of Block Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>), has announced a fresh wave of layoffs at the music streaming service Tidal, which Block owns.
What Happened: Dorsey informed Tidal employees on Wednesday that the company will undergo another significant round of layoffs, <a href="https://fortune.com/2024/10/30/jack-dorsey-layoffs-streaming-music-app-tidal-block-leaked-email/">reported</a> Fortune. The CEO stated that Tidal needs to function &#8220;like a startup again,&#8221; necessitating a much smaller team across the organization.
&#8220;So we're going to part ways with a number of folks on our team,&#8221; Dorsey wrote in the note. &#8220;We're going to lead with engineering and design, and remove the product management and product marketing functions entirely. We're reducing the size of our design team and foundational roles supporting TIDAL, and we will consider reducing engineering over the next few weeks as we have more clarity around leadership going forward.&#8221;
Tidal did not immediately respond to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41590577/bitcoin-breaks-70k-ethereum-and-dogecoin-rise-amid-stock-rally-ahead-of-mag-7-earnings-ana?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Breaks $70K, Ethereum and Dogecoin Rise Amid Stock Rally Ahead Of &#8216;Mag 7&#8217; Earnings: Analyst Says Current Spike Driven By &#8216;Binance Whales&#8217;</a>
Why It Matters: Block acquired a majority stake in Tidal for approximately $300 million in 2021. The music streaming service, founded by Jay-Z, has struggled to compete with platforms like Spotify and Apple Music.
Earlier in October, Cathie Wood&#8216;s Ark Invest <a href="https://www.benzinga.com/markets/equities/24/10/41372553/cathie-wood-continues-to-sell-shares-of-jack-dorseys-bitcoin-focused-company-block-ark-also-dump">sold off a significant amount of shares</a> in Block, despite the company&#8217;s recent positive second-quarter results. This move by Wood, a prominent investor, raised concerns about the future of Block.
However, Block has been making strategic moves in the cryptocurrency space. In August, Dorsey <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40122389/jack-dorsey-views-bitcoin-mining-chip-manufacturing-as-massive-opportunity-for-block-were-">expressed optimism about the potential</a> of the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining chip market, terming it a &#8220;massive opportunity&#8221; for the company. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41618618/microsoft-earnings-are-imminent-here-are-the-recent-forecast-changes-from-wall-streets-most-accurat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Microsoft Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Image Via Shutterstock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Startups

Block CEO Jack Dorsey Announces Another Round Of Layoffs At Tidal

Li Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.42 by 23.8 percent. This is a 15.56 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $6.11 billion which beat the analyst consensus estimate of $5.84 billion by 4.62 percent. This is a 28.55 percent increase over sales of $4.75 billion the same period last year.

CORRECTION: Li Auto Q3 Adj EPS $0.52 Beats $0.42 Estimate, Sales $6.11B Beat $5.84B Estimate

Business Outlook
For the fourth quarter of 2024, the Company expects:
<ul>
<li>Deliveries of vehicles to be between 160,000 and 170,000 vehicles, representing a year-over-year increase of 21.4% to 29.0%. &nbsp;</li>
<li>Total revenues to be between RMB43.2 billion (US$6.2 billion) and RMB45.9 billion (US$6.5 billion), representing a year-over-year increase of 3.5% to 10.0%.</li>
</ul>

Guidance

Li Auto Expects Q4 Revenue Of $6.2B-$6.5B, Deliveries Of 160K-170K (Up By 21.4%-29.0% YoY)

Li Auto Reported Q3 Deliveries Of 152.8K, Up By 45.4% YoY

Farmers &amp; Merchants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMAO#NASDAQ">FMAO</a>) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.42 by 14.29 percent. The company reported quarterly sales of $25.549 million which beat the analyst consensus estimate of $21.567 million by 18.46 percent. This is a 9.53 percent increase over sales of $23.326 million the same period last year.

FMAO

Farmers & Merchants Q3 2024 GAAP EPS $0.48 Beats $0.42 Estimate, Sales $25.549M Beat $21.567M Estimate

New testing method highlights link between protofibrils and biomarkers for neurodegeneration- -Patient and caregiver perspectives on five-year treatment with lecanemab - - Utilization of blood biomarkers to predict brain amyloid accumulation in AHEAD study of preclinical AD-

BIIB

Reported Earlier, Eisai And Biogen Reveal Five-Year Findings On Alzheimer's Treatment Lecanemab At Clinical Trials for Alzheimer's Disease Conference

Sound Financial Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFBC#NASDAQ">SFBC</a>) reported quarterly earnings of $0.45 per share. This is unchanged from the same period last year. The company reported $9.11 million in sales this quarter. This is a 1.52 percent decrease over sales of $9.25 million the same period last year.

SFBC

Sound Financial Bancorp Q3 EPS $0.45, Same YoY, Sales $9.11M Down From $9.25M YoY

The offering is expected to close on November 1, 2024, subject to satisfaction of customary closing conditions. All of the shares of common stock in the offering will be sold by Enovix.
Enovix has granted the underwriter a 30-day option to purchase up to an additional 1,562,500 shares of its common stock offered in the public offering, at the public offering price, less underwriting discounts and commissions.

ENVX

Reported Earlier, Enovix Prices $100M Public Offering Of 10,416,667 Common Shares

CareTrust REIT, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRE#NYSE">CTRE</a>) ("CareTrust REIT" or the "Company") announced the pricing of its upsized underwritten public offering of 13,800,000 shares of common stock at a price to the public of $32.00 per share. The offering is expected to close on November 1, 2024, subject to customary closing conditions. In connection with the offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 2,070,000 shares of common stock.
The Company intends to contribute the net proceeds to CTR Partnership, L.P., its operating partnership, which will in turn use the proceeds from this offering to fund new investments, including to acquire 31 skilled nursing facilities through a joint venture arrangement.

Offerings

CTRE

Reported Earlier, CareTrust REIT Launches $32/Share Upsized Stock Offering of 13.8M Shares (Prior 11.50M) to Fund Nursing Facility Acquisitions

CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium ("CRAC") channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the pricing of an underwritten public offering of 2,720,000 shares of its common stock at a price to the public of $3.75 per share. The gross proceeds to the Company from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $10,200,000. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 408,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares are to be sold by the Company. The offering is expected to close on or about November 1, 2024, subject to satisfaction of customary closing conditions.

CALC

Reported Earlier, CalciMedica Launches $10.2M Stock Offering Of 2.72M Shares At $3.75/Share to Advance Inflammatory Disease Research

CMTL

Reported Earlier, Comtech Appoints Veteran John Ratigan As CEO, Effective October 28

Camping World Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWH#NYSE">CWH</a>) ("Camping World" or the "Company") announced today the pricing of an underwritten public offering of 14,634,146 shares of its Class A common stock (the "Class A Common Stock") at a public offering price of $20.50 per share pursuant to a registration statement filed on Form S-3 with the Securities and Exchange Commission (the "SEC"). Additionally, the Company has granted the underwriters a 30-day option to purchase up to an aggregate of 2,195,121 additional shares of Class A Common Stock. The proceeds of the offering will be used by Camping World to purchase 14,634,146 common units (or 16,829,267 common units if the underwriters exercise their option in full to purchase additional shares of Class A Common Stock) directly from CWGS Enterprises, LLC ("CWGS, LLC"), at a price per unit equal to the public offering price per share of Class A common stock in the offering, less the underwriting discounts and commissions. CWGS, LLC intends to use the net proceeds from the sale of common units to Camping World for general corporate purposes, including strengthening the balance sheet, working capital for growth and debt pay down.

Reported Earlier, Camping World Launches $300M Stock Offering Via Sale Of 14.6M Shares At $20.50/Share to Bolster Growth, Reduce Debt

Tiziana Life Sciences, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that it has entered into a securities purchase agreement for the purchase and sale of 5,263,158 common shares at a purchase price of $0.95 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $5 million, before deducting placement agent commissions and other offering expenses. The closing of the offering is expected to occur on or about November 1, 2024, subject to the satisfaction of customary closing conditions. &nbsp;
In addition, the Company has issued the investor an option to acquire up to an additional 5,263,158 common shares at a price of $0.95 per share until the date that is 75 days from the date of the closing of the offering, resulting in additional gross proceeds of up to approximately $5 million, at the election of the investor.
The Company intends to use the net proceeds from the offering towards (i) its Phase 2a clinical trial for the intranasal delivery of foralumab in patients with non-active secondary progressive multiple sclerosis, (ii) expediting the clinical development of foralumab in Alzheimer's disease, (iii) developing foralumab for other indications, and (iv) for working capital and other general corporate purposes.

TLSA

Reported Earlier, Tiziana Life Sciences Secures $5M in Direct Offering Of 5.3M Shares At $0.95/ Share for Immunotherapy Development

Remitly Global ( ($RELY) ) has shared an announcement. Remitly Global, Inc. has reported a strong third quarter for 2024 with a significant increas...

Remitly Global Reports Strong Q3 2024 Results

For fiscal year 2024, Remitly currently expects: Total revenue in the range of $1.250 billion to $1.254 billion, representing a growth rate of 32% ...

Remitly Global sees FY24 revenue $1.25B-$1.254B, consensus $1.24B

For the fourth quarter of 2024, Remitly currently expects: Total revenue in the range of $338 million to $342 million, representing a growth rate o...

Remitly Global sees Q4 revenue $338M- $342M , consensus $347.74M

Remitly Global Non-GAAP EPS of $0.01 misses by $0.11, revenue of $336.5M beats by $15.95M

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – Root&nbsp;(ROOT)&nbsp;up 70.4...

Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats

Remitly Global, Inc. (RELY) Q3 2024 Earnings Call Transcript

Remitly Global, Inc. ( ($RELY) ) has realeased its Q3 earnings. Here is a breakdown of the information Remitly Global, Inc. presented to its invest...

Remitly Global, Inc. Reports Strong Q3 2024 Results

JMP Securities analyst David Scharf maintained a Buy rating on Remitly Global (RELY – Research Report) today and set a price target of $25.00. The ...

JMP Securities Sticks to Their Buy Rating for Remitly Global (RELY)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Remitly Global (RELY – Research Report), Paylocity...

Analysts Conflicted on These Technology Names: Remitly Global (RELY), Paylocity (PCTY) and KLA (KLAC)

Wells Fargo upgraded Remitly Global (RELY) to Equal Weight from Underweight with a price target of $18, up from $13. Published first on TheFly – th...

Comments

Remitly Global

Notizie

Ultime notizie per Remitly Global (NASDAQ:RELY) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO